Venu Gopal Jonnalagadda (Venugopal Jonnalagadda)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Venues

Archives of Iranian medicine

Diabetes/metabolism research and reviews

Cardiovascular drugs and therapy

mBio

This page only lists publications with an associated author ORCID identifier.

Publications

Venu Gopal Jonnalagadda
EU CTR 536/2014: Are We Able to Reap the Benefits by Now? Archives of Iranian medicine 27 (6) (2024)
Venu Gopal Jonnalagadda
EU CTR 536/2014: Are We Able to Reap the Benefits by Now? Archives of Iranian medicine 27 (6) (2024)
Shahul Hameed P, Harish Kotakonda, Sreevalli Sharma, Radha Nandishaiah, Nainesh Katagihallimath, Ranga Rao, Claire Sadler, Ian Slater, Michael Morton, Abhijeeth Chandrasekaran, Edward J Griffen, Dhanashree Pillai, Sambasiva Reddy, Nagakumar Bharatham, Suryanarayanan Venkatesan, Venu Gopal Jonnalagadda, Ramesh Jayaraman, Mahesh Nanjundappa, Maitrayee Sharma, Savitha Raveendran, Sreenath Rajagopal, Harikrishna Tumma, Amy Watters, Holly Becker, Jill Lindley, Robert Flamm, Michael Huband, Dan Sahm, Meredith Hackel, Tarun Mathur, Ruwanthi Kolamunnage-Dona, Jennifer Unsworth, Laura Mcentee, Nikki Farrington, Dhanasekaran Manickam, Narayana Chandrashekara, Sivakandan Jayachandiran, Hrushikesava Reddy, Sathya Shanker, Vijay Richard, Teby Thomas, Savitha Nagaraj, Santanu Datta, Vasan Sambandamurthy, Vasanthi Ramachandran, Robert Clay, John Tomayko, Shampa Das, Balasubramanian V
BWC0977, a broad-spectrum antibacterial clinical candidate to treat multidrug resistant infections. Nature communications 15 (1) (2024)
Venu Gopal Jonnalagadda
EU CTR 536/2014: Are We Able to Reap the Benefits by Now? Archives of Iranian medicine 27 (6) (2024)
Venu Gopal Jonnalagadda
EU CTR 536/2014: Are We Able to Reap the Benefits by Now? Archives of Iranian medicine 27 (6) (2024)
Venu Gopal Jonnalagadda
Prediabetes with Hypertension and Dyslipidemia: Are They Triad of Future Cardiovascular Risk? Cardiovascular drugs and therapy 33 (6) (2020)
Venu Gopal Jonnalagadda, Harish Prabhanna Char, Pavan Kumar Samudrala
Prediabetes, diabetes mellitus, and anti-diabetic treatment: Is anyone still healthy? Diabetes/metabolism research and reviews 34 (5) (2018)
Venu Gopal Jonnalagadda, Uppulapu Shravan Kumar, Shaik Afsar
Effect of Metformin or Chinese Herbal Formula in Patients with Type 2 Diabetes Mellitus and Hyperlipidemia: A Reassessment. mBio 9 (4) (2018)
Venu Gopal Jonnalagadda, Kanchan Choudhary, Vijay Kranti Matety
Amlodipine Vs. hydrochlorothiazide: is there any disparity in its antihypertensive effect or not? Clinical hypertension 23 (2017)

Venu Gopal Jonnalagadda.css-eqlu8i{font-size:small;padding-left:4px;} (Venugopal Jonnalagadda)

Publication Activity (10 Years)

Top Topics

Top Venues

Venu Gopal Jonnalagadda (Venugopal Jonnalagadda)